1369532-69-3 Usage
Uses
Used in Pharmaceutical Research and Drug Development:
(S)-2-phenyl-1-(thiazol-2-yl)ethanamine is used as a key compound in pharmaceutical research and drug development due to its potential biological activity. Its unique structure allows it to interact with various biological targets, making it a valuable asset in the creation of new medications.
Used in Anti-inflammatory and Analgesic Applications:
In the medical field, (S)-2-phenyl-1-(thiazol-2-yl)ethanamine is used as a precursor for the development of anti-inflammatory and analgesic drugs. Its potential properties in this area make it a promising candidate for the treatment of various conditions that involve inflammation and pain.
Used in Organic Synthesis:
(S)-2-phenyl-1-(thiazol-2-yl)ethanamine is also used as a building block in the synthesis of organic compounds and materials. Its unique structural features, including the presence of both a phenyl and thiazole group, make it a versatile component in the creation of a wide range of chemical products.
Used in Chemical Research:
In the field of chemical research, (S)-2-phenyl-1-(thiazol-2-yl)ethanamine serves as a subject of study for understanding its properties, reactivity, and potential applications in various chemical processes. This research can lead to the discovery of new uses and applications for (S)-2-phenyl-1-(thiazol-2-yl)ethanamine in different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 1369532-69-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,6,9,5,3 and 2 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1369532-69:
(9*1)+(8*3)+(7*6)+(6*9)+(5*5)+(4*3)+(3*2)+(2*6)+(1*9)=193
193 % 10 = 3
So 1369532-69-3 is a valid CAS Registry Number.
1369532-69-3Relevant academic research and scientific papers
PI3 KINASE/mTOR DUAL INHIBITOR
-
, (2012/07/28)
The present invention provides an imidazo[4,5-c]quinolin-2-one compound, or a pharmaceutically acceptable salt thereof, that inhibits both PI3K and mTOR and, therefore, is useful in the treatment of cancer.
